Global X Genomics & Biotechnology ETF
GNOM
GNOM
61 hedge funds and large institutions have $107M invested in Global X Genomics & Biotechnology ETF in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.95M | |
| 2 | +$1.77M | |
| 3 | +$1.34M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$865K |
| 5 |
BS
Banco Santander
Madrid,
Spain
|
+$712K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$1.95M | |
| 3 | -$1.67M | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.26M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.11M |